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Excessive caloric intake leading to obesity is asso-
ciated with insulin resistance and dysfunction of
islet b cells. High-fat feeding decreases desnutrin
(also called ATGL/PNPLA2) levels in islets. Here
we show that desnutrin ablation via RIP-Cre (bKO)
or RIP-CreER results in hyperglycemia with impaired
glucose-stimulated insulin secretion (GSIS). Due to
decreased lipolysis, islets have higher TAG content
but lower free FA levels. bKO islets exhibit impaired
mitochondrial respiration and lower production of
ATP required for GSIS, along with decreased expres-
sion of PPARd target genes involved in mitochon-
drial oxidation. Furthermore, synthetic PPARd, but
not PPARa, agonist restores GSIS and expression
of mitochondrial oxidative genes in bKO mice,
revealing that desnutrin-catalyzed lipolysis gener-
ates PPARd ligands. Finally, adenoviral expression
of desnutrin in bKO islets restores all defects of
bKO islet phenotype and function, including GSIS
andmitochondrial defects, demonstrating the critical
role of the desnutrin-PPARd-mitochondrial oxidation
axis in regulating islet b cell GSIS.
INTRODUCTION
Desnutrin (also called ATGL/iPLA2z/PNPLA2) (Duncan et al.,
2010), a patatin-domain-containing protein, was identified by
us and others as the major triacylglycerol (TAG) hydrolase.
Although desnutrin is highly expressed in adipose tissue, the
main energy storage organ, it is also found in other tissues (Jen-
kins et al., 2004; Villena et al., 2004; Zimmermann et al., 2004).
The product of desnutrin-catalyzed TAG lipolysis, diacylglycerol
(DAG), undergoes further hydrolysis catalyzed by hormone-sen-
sitive lipase (HSL) to generate monoacylglycerol (MAG), which is
finally hydrolyzed by MAG lipase to generate glycerol. Each step
of TAG hydrolysis liberates a fatty acid (FA) (Duncan et al., 2007).Cell MFAs produced from TAG hydrolysis in adipose tissue are
released into circulation to be taken up by other tissues. In
contrast, FAs generated from lipolysis in other tissues where
TAG is found in greatly lesser amount are metabolized primarily
within the cell. High fat diet (HFD) feeding can cause TAG accu-
mulation not only in adipose tissue, but also in various other tis-
sues (Matsui et al., 2004), and lower desnutrin levels or activity
can contribute to TAG accumulation. Ectopic TAG accumulation
in various tissues, such as liver and muscle, has been linked to
metabolic syndrome and insulin resistance. Although molecular
details are not known, increased intracellular lipid metabolites,
as well as mitochondrial dysfunction, have been implicated in
this process.
Excessive caloric or fat intake leading to obesity has been
associated not only with insulin resistance and type 2 diabetes,
but also with b cell dysfunction. In rodents, feeding of a HFD
has been reported to result in islet b cell dysfunction and impair-
ment of insulin secretion (Ehses et al., 2010; Evans-Molina et al.,
2009). It has been well documented that insulin secretion by b
cells is in response to catabolism of metabolic fuels involving
mitochondrial ATP production (Detimary et al., 1998; Lu et al.,
2010). An increase in cytosolic ATP or ATP/ADP ratio induces
closure of the ATP-sensitive potassium channel (KATP), resulting
in plasmamembrane depolarization to allow Ca2+ influx, which in
turn triggers insulin secretion from b cells (Detimary et al., 1998).
Maintaining mitochondrial function is essential to preserve
levels of cellular ATP and insulin secretion. Thus, impairments
in mitochondrial morphology and function have been shown to
decrease insulin secretion, presumably through blunted ATP
production (Lu et al., 2010; Weiss et al., 2012). Still, how mito-
chondrial function for insulin secretion may become perturbed
in type 2 diabetes is not well understood.
The peroxisome proliferator-activated receptor (PPAR) family
of nuclear hormone receptors controls expression of genes
involved in energy homeostasis and lipidmetabolism (Yessoufou
and Wahli, 2010). Of the three PPAR family members, PPARa
is highly expressed in oxidative tissues to play a central role
in FA oxidation, whereas PPARg is preferentially expressed in
adipose tissue to promote adipogenesis and fat storage. In
contrast, PPARd is widely expressed and implicated in both FA
and glucose metabolism. Although PPARs can be activated byetabolism 18, 883–895, December 3, 2013 ª2013 Elsevier Inc. 883
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clearly defined. In this regard, FAs, and in particular unsaturated
FAs, may act as endogenous ligands, or serve as precursors
to generate ligands, to transcriptionally activate target genes.
However, the sources of intracellular FAs that activate PPARs
directly, or indirectly by converting to endogenous ligands,
have not been well understood. We previously reported that,
among the PPAR family of transcription factors, PPARa is the
most highly expressed in brown adipose tissue and desnutrin-
catalyzed lipolysis provides endogenous ligands for PPARa to
promote mitochondrial function and to maintain brown adipose
phenotype (Ahmadian et al., 2011). Similarly, Zechner and co-
workers reported desnutrin-mediated promotion of FA oxidation
through PPARa in cardiac muscle (Haemmerle et al., 2011).
These studies suggest that activation of PPARa by FAs, or other
metabolites, is a common feature for desnutrin-catalyzed TAG
hydrolysis.
Here, we report that ablation of desnutrin in islet b cells impairs
glucose-stimulated insulin secretion (GSIS). Desnutrin ablation
using RIP-Cre or RIP-CreER in mice results in TAG accumulation
in islets, leading to pronounced hyperglycemia. Adenovirus-
mediated desnutrin expression in b cell knockout (bKO) islets
restores GSIS. Furthermore, we show that desnutrin-catalyzed
lipolysis activates PPARd, rather than PPARa, which in turn is
critical for expression of genes involved in mitochondrial func-
tion, and thus ATP production, required for GSIS.
RESULTS
Desnutrin Ablation in Pancreatic b Cells Causes
Glucose Intolerance in Mice
Recent studies have shown that a HFD can cause pancreatic b
cell dysfunction and impair insulin secretion in mice (Ehses
et al., 2010; Evans-Molina et al., 2009). HFD can elevate TAG
content in pancreatic islets. To examine the potential involve-
ment of desnutrin in this process, we examined whether
desnutrin expression is altered by HFD feeding. Indeed, both
desnutrin protein and mRNA levels in pancreatic islets were
approximately 50% lower in HFD group compared to standard
chow diet group (Figure 1A, left). Accordingly, TAG content in
islets was increased by more than 40% upon HFD feeding
(Figure 1A, right). These observations suggest that desnutrin
is associated with TAG accumulation in pancreatic islets
and desnutrin may play a role in b cell dysfunction induced
by HFD.
To understand desnutrin function in b cells, we generated a
targeting vector by inserting LoxP and FRT sites flanking the first
exon of desnutrin to produce desnutrin-floxed mice (Ahmadian
et al., 2011). We crossed rat insulin II promoter-Cre transgenic
mice (RIP-Cre) with mice homozygous for desnutrin-floxed
alleles for generation of tissue-specific desnutrin bKO mice.
Mice were born at the expected Mendelian frequency and
exhibited normal life expectancy. Compared to control, flox/
flox (floxed), or RIP-Cre mice, desnutrin mRNA levels were
decreased by 80% in the islets of bKO mice. Desnutrin expres-
sion in other tissues showed no apparent changes (Figure 1B,
inset). Immunoblotting showed no detectable desnutrin protein
levels in islets of bKO mice. Of note, although it has been re-
ported that RIP-Cre can also be expressed and affect hypotha-884 Cell Metabolism 18, 883–895, December 3, 2013 ª2013 Elsevierlamic gene expression (Kubota et al., 2004), we did not detect
significant differences in mRNA or protein levels of desnutrin in
the hypothalamus between bKO and control mice (Figure 1B
and Figure S1A available online).
Next, bKO and control floxed or RIP-Cre mice were fed a
standard chow or HFD at 4 weeks of age, and mice were exam-
ined at 8 weeks of age. There were no differences in food intake
or body weights of bKO in comparison to floxed or RIP-Cre
mice on either chow or HFD (Figure S1B). All subsequent
studies were performed on bKO and control floxed or RIP-
Cre mice maintained on HFD. (Initial studies were performed
on mice on chow as well as HFD, as indicated.) No significant
differences in fasting plasma levels of NEFA, TAG, glucose, or
insulin were detected between groups (Figures 1C and S1C).
bKO mice on a HFD showed higher postprandial blood glucose
and lower insulin levels when compared to the floxed or RIP-
Cre mice on HFD (Figure 1C). We next performed glucose toler-
ance tests (GTTs) and insulin tolerance tests (ITTs). During
GTTs of mice on HFD, blood glucose levels of bKO mice at
30 and 60 min were 33% and 30% higher than control groups,
respectively (Figure 1D, left). However, we did not detect any
alternations in ITT compared to floxed or RIP-Cre mice on
chow or HFD diet, strongly suggesting a defect in insulin secre-
tion in bKO mice, especially upon HFD feeding (Figures 1D and
S1D, right). Examination of insulin levels during the first 30 min
after glucose administration during the GTT indicated that,
unlike floxed or RIP-Cre groups with a significant increase in
insulin levels from 1.3- to 1.5-fold, bKO mice were unable to
raise insulin levels in response to a glucose challenge (Fig-
ure 1E, left). We also measured C-peptide levels, which, due
to its longer half-life, can be a more sensitive index for insulin
secretion. Indeed, C-peptide levels were elevated by approxi-
mately 3-fold 30 min after glucose administration in floxed or
RIP-Cre mice, whereas the levels did not change in bKO mice
(Figure 1E, right). These results point to the idea that insulin
secretory function of b cells may be defective in desnutrin
bKO mice on a HFD and that the lower desnutrin levels we
detected upon HFD feeding may contribute to HFD-associated
b cell dysfunction. We also detected similar alterations in b cells
function of bKO mice on chow diet. Glucose levels throughout
GTT were somewhat higher in bKO mice on chow diet, although
they were not statistically significant (Figure S1D, left). Insulin
levels during GTT of chow-fed bKO mice, however, were greatly
lower, confirming the idea of defective GSIS caused by desnu-
trin ablation (Figure S1D, middle). In this regard, impairment in
insulin secretion in RIP-Cre mice has been described in some
reports (Lee et al., 2006). On the other hand, others have re-
ported unaltered glucose tolerance in RIP-Cre mice when
bred onto a pure C57BL/6 background (Fex et al., 2007). In
our studies, control RIP-Cre mice did not show any impairment
in insulin secretion and had the same glucose and insulin
tolerance as floxed mice. Unaltered glucose tolerance in our
RIP-Cre mice probably was due to the relatively young
8-week-old male mice on a pure C57BL/6J background that
we employed in our studies. To prevent any developmental
effect from using RIP-Cre mice, we also employed a tamox-
ifen-inducible RIP-CreER mouse model. In this regard, this
model has been reported to have a very low, but detectable,
leakiness in the Cre expression (Liu et al., 2010; Russ et al.,Inc.
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Figure 1. GTT and ITT in Desnutrin bKO Mice
(A) Immunoblotting (left top) and RT-qPCR for desnutrin (left bottom) in pancreatic islets of C57BL/6 mice; TAG content in pancreatic islets (right).
(B) Immunoblotting (top) and RT-qPCR (bottom) for desnutrin expression in islets.
(C) Blood glucose and plasma insulin levels in mice.
(D) GTT (left) and ITT in mice (middle), and GTT in RIP-CreER mice treated with tamoxifen (right).
(E) Plasma insulin (left) and C-peptide levels (right) during GTT. Male mice, n = 6–10. Data are shown as mean ± SEM; *p < 0.05, **p < 0.01. See also Table S1 and
Figure S1.
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Desnutrin/ATGL and PPARd in Insulin Secretion2009). Our homozygous desnutrin-floxed mice were mated
with RIP-CreER mice and, after five injections of tamoxifen in
a 2 week period, GTT was performed. The blood glucose levels
30 min after glucose administration were 37% higher in these
temporal bKO mice (RIP-CreER-desnutrin-KO) compared to
floxed or RIP-Cre-ER mice (Figure 1D, right). The degree of
glucose intolerance observed in these temporal desnutrin-KO
mice was similar to that in RIP-Cre-bKO mice. Overall, our re-
sults are consistent with the notion that bKO mice may have
defective insulin secretion from islet b cells when challenged
with glucose.Cell MAblation of Desnutrin in b Cells Impairs
Glucose-Stimulated Insulin Secretion
To examine whether lack of desnutrin affects islet b cell pheno-
type, we examined the morphology of pancreatic islets and also
measured islet insulin levels. Hematoxylin and eosin (H&E) stain-
ing and quantification showed that the average islet size of bKO
pancreas was larger approximately by 120% compared to
floxed or RIP-Cre pancreas (Figure 2A, left and middle).
We also found that the bKO pancreas contained a higher fre-
quency of larger-sized islets by measuring and counting islets
of cryosections of pancreas (Figure 2A, right). In addition,etabolism 18, 883–895, December 3, 2013 ª2013 Elsevier Inc. 885
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Figure 2. Islet Size, Insulin Content, and GSIS in bKO Islets
(A) Hematoxylin and eosin (H&E) staining of cryosections from pancreas (left), average islet area (middle), and frequency of islet size (right); scale: 100 mm.
(B) Immunostaining for insulin (green), glucagon (red), and DAPI (blue) staining (left); scale: 75 mm. Insulin content in whole pancreas (middle) and islets (right).
(C) Transmission electron microscopy of isolated islets (left) and number of insulin granules per area (right); scale: 0.5 mm.
(D) GSIS in isolated islets (left) and in dispersed b cells (right).
(E) Immunoblotting for desnutrin in bKO islets infected with adenoviral GFP or desnutrin GFP. Bottom arrow: endogenous desnutrin; upper arrow: desnutrin-GFP
(left). GSIS in dispersed bKO islet cells infected with adenoviral GFP or desnutrin GFP (right). Male mice, n = 5–8. Data are represented as mean ± SEM; *p < 0.05,
**p < 0.01. See also Figure S2.
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Desnutrin/ATGL and PPARd in Insulin Secretionimmunostaining showed stronger intensity of insulin staining
(green) in bKO islets than in control islets (Figure 2B, left). Consis-
tent with stronger insulin staining, the content of insulin was 69%886 Cell Metabolism 18, 883–895, December 3, 2013 ª2013 Elsevierand 45% higher in whole pancreas and isolated islets, respec-
tively, in bKO mouse compared to floxed mice (Figure 2B, mid-
dle). Electron microscopy indicated a higher density of insulinInc.
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Desnutrin/ATGL and PPARd in Insulin Secretiongranules in bKO islets (Figure 2C, left), and quantification showed
the number of insulin granules higher by 50% in bKO islets than in
control islets from floxed mice (Figure 2C, right). However,
despite this increase in insulin content in the bKO islets, there
were no significant differences in INS1 and INS2 mRNA levels
in bKO islets compared to floxed or RIP-Cre islets (Figure S1F).
These findings indicate that insulin synthesis was not affected
in bKO islets.
We next tested whether the lack of increase in insulin levels
upon glucose challenge in bKO mice, especially with the
increased insulin content in islets of bKOmice, reflects defective
insulin secretion. Pancreatic islets were isolated from bKO and
floxed mice, and islets were incubated with increasing concen-
trations of glucose. We detected increased insulin levels in cul-
ture media from floxed islets, and insulin levels displayed a
dose dependence in response to increasing glucose levels (Fig-
ure 2D, left). In contrast, the increase in insulin levels detected in
culture media from bKO islets was significantly blunted upon a
15 and 30 mM glucose challenge (Figure 2D, left). In order to
eliminate cell-to-cell interaction and to minimize the cell number
variation arising from the differences in islet size, we next used
dispersed islet cells, representing mainly b cells by eliminating
non-b cells through centrifugal elutriation. At 5min after the addi-
tion of glucose, cells from floxed mice showed a marked in-
crease in insulin secretion (a 1.7-fold higher insulin level), which
was maintained up to 60 min. In contrast, cells from bKO mice
showed only a slight increase in insulin levels of approximately
20% (Figure 2D, right) at all time points, clearly demonstrating
defects in insulin secretion upon desnutrin ablation. This time
course also demonstrates the early effect of desnutrin on insulin
secretion. To confirm that this reduced secretory response
was attributed to desnutrin deficiency per se, we transduced
dispersed islet cells from bKO mice with adenovirus expressing
desnutrin. As verified by immunoblotting, desnutrin level was
significantly increased in the bKO islet cells infected with desnu-
trin-GFP (bKO+Ad-desnutrin) compared to the control bKO islet
cells infected with GFP only (bKO+Ad-GFP) (Figure 2E, left). At
48 hr postinfection, insulin levels in desnutrin bKO cells overex-
pressing desnutrin were already slightly higher than in control
cells. Ten minutes after 20 mM glucose stimulation, insulin level
increased only slightly in bKO-GFP cells, and this low level was
maintained throughout the time points, consistent with the
defective insulin secretion (Figures 2D and 2E, right). In contrast,
insulin release in desnutrin-infected bKO islet cells was
increased significantly to almost 2-fold over control cells and
was maintained throughout the time course (Figure 2E, right).
These data indicate that desnutrin expression restores insulin
secretion from bKO islets. We also performed lentivirus-medi-
ated shRNA knockdown. shRNA knockdown of desnutrin in
INS-1-derived 832/13 cells (INS 832/13 cells) caused an approx-
imately 50% decrease in desnutrin levels compared to control-
scrambled shRNA lentivirus-infected cells (Figure S2A, left).
Whereas glucose caused a dose-dependent increase in insulin
secretion in control cells, desnutrin knockdown resulted in a
significantly blunted insulin secretion upon addition of 15 or
30 mM glucose (Figure S2A, middle). An increase in insulin level
was detected in control cells 5min after the glucose addition and
continued to increase up to 60 min. In desnutrin knockdown
cells, however, insulin secretion was significantly blunted (Fig-Cell Mure S2A, right). Conversely, cells infected with desnutrin adeno-
virus, having approximately 5-fold increase in desnutrin levels
(Figure S2B, left), showed higher GSIS when compared to GFP
cells, although both cells had a typical dose- and time-depen-
dent increase (Figure S2B, middle and right).
Overall, our studies on GSIS from isolated islets and dispersed
islet cells from bKO mice, along with the apparent accumulation
of insulin granules in bKO islets, point to the role of desnutrin in
the insulin secretory process. Moreover, adenoviral rescue ex-
periments clearly demonstrate that desnutrin functions in islet
b cells for proper GSIS.
Desnutrin-Catalyzed Lipolysis Controls TAG and FA
Content and FA Utilization in Islet b Cells
Desnutrin has originally been identified to serve as the major
lipase catalyzing the hydrolysis of TAG in adipose tissue. TAG
accumulation due to desnutrin ablation induces adipocyte
hypertrophy (Ahmadian et al., 2011; Villena et al., 2004). It has
been shown that TAG can accumulate in pancreatic b cells,
especially upon high-fat feeding (Okazaki et al., 2010). We there-
fore measured TAG content in bKO islets. Total TAG levels
extracted from whole pancreas and isolated islets from bKO
mice in comparison to floxed mice were 1.5- and 2-fold higher,
respectively (Figure 3A, top). Nile red staining for lipids also
showed a lipid accumulation in islets from bKO mice, presum-
ably due to a decrease in TAG hydrolysis due to lack of desnutrin
(Figure 3A, bottom). However, there were no alterations in DAG
content in the bKO islets (Figure S3A). Intracellular content of
nonesterified FAs was determined to be 34% lower in the bKO
islets (Figure 3B, left). Glycerol release determined as a measure
of lipolysis was significantly lower in islets from bKO mice (Fig-
ure 3B, right). Taken together, we conclude that desnutrin
activity is essential for the hydrolysis of TAG in islet b cells. We
propose that the accumulation of TAG in islet b cells might
contribute to the increased islet size in bKO mice (Figure 2A).
To further confirm the role of desnutrin-catalyzed lipolysis in
islet b cells, we performed adenovirus-mediated overexpression
of desnutrin in INS 832/13 cells. TAG content as judged by Nile
red staining, as well as measurement of TAG from lipid extrac-
tion, was decreased greatly upon desnutrin overexpression (Fig-
ure 3C, top). Glycerol release, and thus lipolysis, was increased
significantly upon desnutrin overexpression (Figure 3C, bottom
left). Consistent with our previous studies in adipocytes (Ahma-
dian et al., 2009), FA oxidation in desnutrin-overexpressing INS
832/13 cells was also increased (Figure 3C, bottom right), while
FA uptake was not significantly changed (Figure S3B). These
data clearly demonstrate that desnutrin regulates lipolysis in islet
b cells to control intracellular TAG and free FA levels and affect
FA oxidation. Since desnutrin-catalyzed lipolysis affects intracel-
lular FA levels in islet b cells, we next tested whether supplemen-
tation with exogenous FAs could restore the GSIS in bKO islet
cells. We added oleate into dispersed islet cells. As predicted,
addition of oleate caused a robust increase in insulin release in
islet cells from floxed mice. In contrast, addition of oleate to
dispersed islet cells from desnutrin bKO mice did not cause an
increase in insulin release (Figure S3C), demonstrating that
exogenous FAs could not substitute for desnutrin-catalyzed
lipolysis. Overall, these results clearly show the specific role of
desnutrin-catalyzed lipolysis in GSIS.etabolism 18, 883–895, December 3, 2013 ª2013 Elsevier Inc. 887
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Figure 3. TAG Content and Lipolysis in bKO Islets
(A) Content of TAG of whole pancreas (top left) or isolated islets (top right) and
Nile red staining for TAG in islets (bottom); scale: 50 mm.
(B) FA content in islets (left) and glycerol release from islets (right). Male mice,
n = 4–6.
(C) Content of TAG (top left), Nile red and DAPI staining (top right), glycerol
release (bottom left), and FA oxidation (bottom right) in INS 832/13 cells in-
fected with adenoviral desnutrin GFP or control GFP (n = 3–4). Data are shown
as mean ± SEM; *p < 0.05, **p < 0.01. See also Figure S3.
Cell Metabolism
Desnutrin/ATGL and PPARd in Insulin Secretion
888 Cell Metabolism 18, 883–895, December 3, 2013 ª2013 ElsevierDesnutrin Promotes Mitochondrial Function and ATP
Production in b Cells
As we have observed in adipocytes, we found increased FA
oxidation by desnutrin overexpression in b cells. However, exog-
enous FAs could not restore impaired GSIS brought on by
desnutrin ablation. Therefore, we next examined mitochondrial
function of bKO islets. Mitochondrial membrane potential has
been regarded as a sensitive marker of mitochondrial activity.
Hence, we used glucose-treated dispersed islet cells to examine
mitochondrial membrane potential. We employed MitoTracker
red, which stains functional mitochondria, and MitoTracker
green, which stains total mitochondria independent of mitochon-
drial membrane potential (Figure 4A, left). As shown in confocal
fluorescence microscopy, although islet b cells from desnutrin
bKOmice are larger, they showed similar staining of MitoTracker
green when compared to control cells from floxed mice. On the
other hand, bKO cells had very low MitoTracker red staining
when compared to floxed cells. Thus, the density of functional
mitochondria, as expressed as MitoTracker red/green ratio,
was decreased by 50% in bKO cells (Figure 4A, right). The total
mitochondrial density as reflected by mitochondrial DNA
(mtDNA) to nuclear DNA ratio remained similar in the floxed
and bKO islets (Figure 4B). Additionally, we stained functional
mitochondria in desnutrin overexpressing INS 832/13 cells.
Overexpression of desnutrin resulted in an increase in
MitoTracker red staining over GFP control cells, showing that
overexpression of desnutrin caused an enhancement of mito-
chondrial activity (Figure S4B). We conclude that impaired
GSIS caused by ablation of desnutrin in islet b cells accom-
panies diminished mitochondrial function. Some mitochondria
appeared to be fused together in bKO islets with increased
expression of Mitofusin 1 and 2 and Fis-1 (Figures S4C and S4D).
Next, we examined expression levels for those genes involved
in mitochondrial oxidation, such as Mdh2 and Sdhb, which are
involved in the TCA cycle and may regulate GSIS. We examined
expression of Cpt2, Acadvl, and Hadhb, which are also related
to FA oxidation (Roberts et al., 2011). We found a significant
decrease in mRNA levels for all of these genes in bKO islets
compared to floxed islets (Figure 4C, top left), while expression
of SNAP25, Stx1a, and Vamp2, which are related to exocytosis,
was not changed (Figure 4C, top right). Thus, gene expression
data also support the notion of the defect in mitochondrial
oxidative function in bKO cells.
To further investigate mitochondrial function of bKO islets, we
measured islet oxygen consumption rate (OCR) employing the
XF24 respirometer platform (Wikstrom et al., 2012). After a 2 hr
preincubation in 3 mM glucose, control floxed islets stimulated
with 20 mM glucose responded robustly by increasing their
OCR to about 2-fold of the basal level. However, bKO islets
only showed a 1.2-fold increase. Addition of 5 mM oligomycin,
which inhibits ATP synthase, resulted in a decrease in respiration
to the similar level in both floxed and bKO islets. Addition of 1 mM
FCCP, which causes uncoupling of the oxidative phosphoryla-
tion from the electron transport chain, led to a sharp, 2.4-fold in-
crease over the basal level of OCR in floxed islets. In contrast, the
increase of OCR by FCCP was only 1.6-fold in the bKO islets,
indicative of lower respiratory capacity. As expected, injection
of 5 mM rotenone resulted in OCR shut down in both groups
(Figure 4C, bottom left). We also measured activity of citrateInc.
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Figure 4. Desnutrin Is Required for Mitochondrial Function
(A) MitoTracker red/green staining of mitochondria in dispersed b cells (left); scale: 100 mm. Quantification of MitoTracker red/green ratio (right).
(B) Mitochondrial DNA to nuclear DNA ratio.
(C) RT-qPCR ofmitochondrial function related genes (top left) and unrelated genes (top right), OCR (bottom left), CS activity (bottommiddle), and ATP/ADP ratio in
isolated islets (bottom right).
(D) RT-qPCR (top right and left), OCR (bottom left), and ATP/ADP ratio (bottom right) in bKO islets infected with adenoviral GFP or desnutrin GFP. Data are shown
as mean ± SEM; *p < 0.05, **p < 0.01. See also Figure S4.
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Figure 5. Desnutrin Regulates GSIS by Activating PPARd
(A) RT-qPCR of PPARa, PPARd, and PPARg in islets.
(B) GTT of mice treated with the PPARd agonist, GW501516 (left), or fed with PPARa agonist, WY 14643 (right).
(C) GSIS of isolated islets from GW501516-treated mice.
(legend continued on next page)
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Desnutrin/ATGL and PPARd in Insulin Secretionsynthase (CS), which is a rate-limiting enzyme in the Krebs cycle.
CS activity was significantly lower in islets from bKOmice than in
those from control mice, confirming impairment of mitochondrial
oxidative function in desnutrin-KO b cells (Figure 4C, bottom
middle). Next, we tested the effect of desnutrin ablation on pro-
duction of ATP known to be required for the triggering of insulin
secretion. Isolated islets were incubated with increasing con-
centrations of glucose before measuring ATP and ADP levels
and determining ATP/ADP ratio. We found a dose-dependent in-
crease in ATP/ADP ratio in islets from control, floxed, or RIP-Cre
mice (Figure 4C, bottom right; Figure S4A). In contrast, ATP/ADP
ratio in bKO islets showed a blunted rise upon glucose stimula-
tion (Figure 4C, bottom right). Decreased ATP/ADP ratio in
bKO islets and restoration of ATP/ADP ratio by desnutrin over-
expression (Figure 4D, bottom right) were correlated with the
changes in GSIS, as shown in Figures 2D and 2E. Although
FAs and their metabolites have been implicated in controlling
KATP channels and insulin granule exocytosis in b cells
(Komatsu et al., 1999; Nolan and Prentki, 2008), we did not
detect any changes in KCl-stimulated basal insulin secretion in
desnutrin-ablated bKO islets (Figure S2D) or in INS 832/13 cells
upon desnutrin overexpression or knockdown. In addition, we
did not detect significant alterations in insulin secretion in bKO
islets in the presence of KCl and with the KATP channel opener,
diazoxide, 5min after 10mMglucose addition, a time point when
we could clearly detect desnutrin effect on GSIS as shown in Fig-
ure 2D, right panel (Figure S2E). We also did not detect associa-
tion of desnutrin with insulin granules, which was reported with
HSL (Lindvall et al., 2004). Nor did we detect any changes in
mRNA levels for genes involved in vesicle exocytosis, such as
Vamp2, Stx1a, and SNAP25 (Figure 4C, top right; Bhatnagar
et al., 2011; Hou et al., 2009), suggesting that capacity for insulin
granule exocytosis was not affected by desnutrin-catalyzed
lipolysis. Overall, our results support the idea that impaired
GSIS in bKO islets is correlated with impaired mitochondrial
function and ATP production required for insulin secretion.
To confirm that mitochondrial dysfunction in bKO islets is
specifically due to desnutrin deficiency, we performed rescue
experiments by adenoviral desnutrin expression to bKO islets
(Figure 2E). We found that desnutrin overexpression increased
mRNA levels of genes involved in mitochondrial oxidation, such
as Cpt2, Acadvl, Hadhb, and Sdhb (Figure 4D, top left). In addi-
tion, OCR performed in bKO islets after adenoviral overexpres-
sion of desnutrin also increased OCR, restoring the oxidative
capacity (Figure 4D, bottom left). Upon adenoviral overexpres-
sion of desnutrin, ATP/ADP ratio in bKO islets was also increased
when stimulated with glucose, evidence that impaired GSIS by
desnutrin ablation in b cells is most likely due to impaired mito-
chondrial oxidationandATPproduction (Figure 4D, bottom right).
PPARd Mediates the Effects of Desnutrin-Catalyzed
Lipolysis on Insulin Secretion
We and others reported that desnutrin-catalyzed lipolysis pro-
vides ligands for PPARa to promote mitochondrial function and(D) GSIS of isolated islets from WY 14643-treated mice.
(E) PPARd (left) and PPARa (middle) binding activity in islet nuclear extracts and
(F) RT-qPCR in isolated islets from mice treated with GW501516. Male mice, n =
(G) Schematic diagram of desnutrin-PPARd-mitochondrial axis. See also Figure
Cell MFA oxidation in brown adipose tissue, as well as in the heart
(Ahmadian et al., 2011; Haemmerle et al., 2011). Therefore, we
hypothesized that desnutrin-catalyzed lipolysis in islet b cells
may also affect PPARa. However, unlike brown adipose or mus-
cle tissues that have high PPARa levels, we found PPARa level in
islets to be very low and PPARd to be the most highly expressed
among the PPARs (Figure 5A). We predicted that, rather than
PPARa, PPARd may mediate effects of desnutrin-catalyzed
lipolysis in islet b cell function. To test this possibility, we
administered a PPARd agonist, GW501516, to floxed and bKO
mice by intraperitoneal injection for 2 weeks. Administration of
GW501516 to floxed mice did not alter glucose tolerance signif-
icantly. Administration of GW501516 to bKO mice, however,
improved glucose intolerance resulting from b cell-specific des-
nutrin deletion to the level of tolerance found in floxed mice
(Figure 5B, left), suggesting that GW501516 can substitute for
desnutrin. We also performed similar experiments with a PPARa
agonist, WY14643, which was given to floxed and bKO mice in
their food after weaning. However, glucose tolerance in bKO
mice treated with WY14643 was not different from untreated
bKOmice, pointing to the specificity of PPARd (Figure 5B, right).
We next measured insulin secretion upon 15 and 30 mM
glucose stimulation in islets from bKO and floxed mice treated
with GW501516 or WY14643. Consistent with the GTT results,
impaired GSIS observed in islets from bKO mice was restored
by treatment with GW501516 (15 mM GSIS: floxed 111, bKO
70; GW501516: floxed 150, bKO 132 pg/islet/2 hr) (Figure 5C).
However, WY14643 treatment did not affect GSIS in bKO islets
(15 mM GSIS: floxed 111, bKO 70; WY14643: floxed 101, bKO
72 pg/islet/2 hr) (Figure 5D). It is clear that activation of PPARd,
but not PPARa, was able to rescue the bKO islets in regards to
insulin secretion. To test if the GW501516 effect we observed
in bKO mice was due to its effect on islet b cells, we utilized
lentivirus-mediated desnutrin knockdown in INS 832/13 cells.
As shown in Figure S2A, GSIS in INS 832/13 cells was signifi-
cantly decreased upon desnutrin knockdown. More importantly,
treatment of desnutrin knockdown cells with GW501516
restored the GSIS to normal levels (Figure S4E). These results
show that desnutrin-catalyzed lipolysis affect GSIS probably
via activation of PPARd in islet b cells.
Next, to further demonstrate alterations in PPAR function,
nuclear extracts prepared from islets of floxed and bKO mice
were assayed for PPARd, as well as PPARa, binding activity.
There was a significant decrease in PPARd binding activity in
the bKO islets compared to control floxed islets (Figure 5E,
left). In contrast, there was no significant difference in PPARa
binding activity between the islets from floxed and bKO mice
(Figure 5E, middle). Furthermore, we observed greatly increased
PPARd binding activity in the islets from bKO mice upon admin-
istration of GW501516 (Figure 5E, right), showing that desnutrin-
catalyzed lipolysis specifically increases PPARd binding. We
also examined whether lack of desnutrin results in alterations
in expression levels of various PPARd target genes. Indeed,
mitochondrial oxidation-related genes, such as Pdk4, Cpt1bPPARd binding activity from GW501516-treated mice (right).
4–6. Data are shown as mean ± SEM; *p < 0.05, **p < 0.01.
S4.
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Acadvl, which are known to be PPARd target genes, were all
downregulated in the bKO islets. Furthermore, treatment with
GW501516 restored expression levels of these genes to normal
(Figure 5F). Yet other genes, such as Vamp2 and SNAP25 for
exocytosis, were not changed. Taken together, our results
indicate that desnutrin provides ligands for PPARd to activate
PPARd target genes in islet b cells. Thus, desnutrin promotes
maintenance of mitochondrial function required for GSIS in islet
b cells.
DISCUSSION
While FAs generated upon lipolysis in white adipose tissue are
released into the circulation to provide an energy source for other
tissues, we show here that lipolysis within the b cells is essential
for mitochondrial function by providing ligands for PPARd. Our
findings in vivo, in isolated islets, as well as in b cells in culture,
all show that desnutrin is required for proper GSIS. We provide
evidence for the importance of desnutrin activity in maintaining
the mitochondrial oxidation/respiration and ATP production for
the facilitation of insulin secretion. Our present studies reveal a
critical link between desnutrin-catalyzed lipolysis and PPARd
activation in islet b cells.
Nutrition overload, such as HFD, induces ectopic TAG stor-
age. It has been reported that TAG accumulation may occur
with lower levels of enzymes in TAG hydrolysis in various tissues,
including pancreatic islets (Winzell et al., 2003). In line with this,
we detected high TAG accumulation with decreased desnutrin
expression in islets of HFD-fed mice. Excess TAG storage in b
cells is associated with a negative impact on insulin secretion
(Unger, 2002). However, it is unclear whether TAG accumulation
per se or other lipid metabolites contribute to the failure of GSIS
from b cells. In this process, importance of glycerolipid/FA
cycling has also been proposed. In this regard, we and others
identified desnutrin (adipose triglyceride lipase, TTS-2, iPLA2-
d, and PNPLA2) as the primary TAG hydrolase in white adipose
tissue. Desnutrin, however, is also found in other tissues, albeit
at a low level. Thus, global deletion of desnutrin results in
massive TAG accumulation in multiple tissues, in addition to ad-
ipose tissue, and causes premature death in mice (Haemmerle
et al., 2006), suggesting the importance of desnutrin activity in
other tissues besides adipose tissue. In addition to desnutrin,
HSL, which is now accepted to be a DAG lipase, is also found
in pancreatic b cells, and these lipasesmay function in regulating
GSIS (Fex et al., 2009; Peyot et al., 2009; Winzell et al., 2001).
However, studies employing global knockout desnutrin/ATGL
knockout (desnutrin-KO) or HSL knockout (HSL-KO) mice
showed conflicting results: global HSL-KO mice were reported
to have perturbed insulin secretion in vivo or vigorous GSIS
ex vivo (Peyot et al., 2004; Roduit et al., 2001). Global desnu-
trin-KO mice were shown to be protected from HFD-induced
insulin resistance and glucose intolerance, while others found
them to be hypoinsulinemic and hypoglycemic (Hoy et al.,
2011; Peyot et al., 2009). In addition, global desnutrin-KO mice
had 50% reduction in insulin content in islets, and glucose oxida-
tion was reported to be unaltered (Peyot et al., 2009). These
studies on global knockout mice could not distinguish indirect
from direct events within the islets, and conflicting results may892 Cell Metabolism 18, 883–895, December 3, 2013 ª2013 Elsevierarise under different physiological conditions (Peyot et al.,
2009; Peyot et al., 2004). In our present studies, b cell-specific
desnutrin deletion showed glucose intolerance, but with
increased insulin content and insulin granules in islets, with
defective GSIS. The differences in phenotypes between our spe-
cific deletion of desnutrin in b cells and global desnutrin-KOmice
clearly show the influence of peripheral tissue lipid metabolism
on islet function and demonstrate the validity of our present
work in dissecting the function of intracellular b cell TAG
metabolism. Interestingly, unlike our bKO mice, HSL-bKO mice
generated using the same RIP-Cre mice did not show any lipid
accumulation within the islets (Fex et al., 2009). Yet, similar to
our desnutrin bKO mice, HSL-bKO mice had hyperglycemia
with increased insulin content and islet mass (Fex et al., 2009).
These observations suggest that TAG accumulation per se
may not affect GSIS. In this regard, HSL has been reported to
associate with the insulin granule to affect membrane depolari-
zation in promoting exocytosis (Fex et al., 2009; Lindvall et al.,
2004), and KATP-independent effects of HSL on insulin secretion
have been reported. In addition, desnutrin-catalyzed lipolysis
has been implicated in controlling KATP channel for GSIS. How-
ever, we detected neither desnutrin association with insulin
granule nor alterations in KATP channel activity in desnutrin
loss- or gain-of-function experiments (Figure S2D). Regardless,
the discordant phenotype between the b cell-specific desnutrin
and HSL ablation suggests that these lipases affect GSIS via
divergent mechanisms.
Although widely utilized, the validity of the RIP-Cre mouse
model has been questioned due to some reports indicating
RIP-Cre expression in hypothalamic region and that expression
of Cre itself impaired glucose/insulin homeostasis (Lee et al.,
2006). Here, although other b cell-specific Cre lines have been
reported recently, due to accessibility, we have used RIP-Cre
mice in generating desnutrin bKO mice. However, we did not
detect significant changes in desnutrin expression in hypothala-
mus, even when desnutrin expression was 80% lower in islets
upon mating of desnutrin floxed mice with RIP-Cre mice. Nor
did we detect impaired glucose/insulin homeostasis in our con-
trol RIP-Cre mice, probably due to the relatively young age of
mice (8 weeks) and their pure C57BL/6 background, as previ-
ously reported (Fex et al., 2007). In addition, temporal ablation
of desnutrin only in adult stage by RIP-CreER (Liu et al., 2010)
confirmed the phenotype of our bKO mice using RIP-Cre mice.
More importantly, our studies of restoration of GSIS by adeno-
virus-mediated overexpression of desnutrin in bKO islet cells
clearly demonstrate that lack of desnutrin in b cells is responsible
for the observed defects in GSIS in bKO mice.
Mitochondrial oxidation is essential for production of ATP
required for GSIS. Mitochondrial anaplerosis and mitochon-
drial-cytosolic substrate cycling regulate insulin secretion (Cline,
2011; Jitrapakdee et al., 2010). Here, we show that desnutrin-
catalyzed lipolysis regulates GSIS by promoting mitochondrial
respiration in b cells. Consistent with a low mitochondrial
capacity, we detected a blunted increase in ATP/ADP ratio
in bKO islets upon glucose stimulation. We also detected
decreased density of active mitochondria without changes in to-
tal mitochondrial density and lower CS activity. OCR in response
to glucose and to uncoupling agent, FCCP, were both lower in
the bKO islets. Furthermore, we detected downregulation ofInc.
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Among those genes were Mdh2 and Sdhb, enzymes involved
in the TCA cycle that are critical for glucose oxidation during
GSIS. Others, such as Hadhb, Cpt1b, Cpt2, Pdk4, and Acadvl,
which are involved in FA metabolism in mitochondria, were
also downregulated. Importantly, adenovirus-mediated desnu-
trin expression rescued all of those defects observed in bKO is-
lets, including expression of the genes involved in mitochondrial
oxidative function, OCR, and ATP/ADP ratio. It is clear that des-
nutrin promotes oxidative capacity of mitochondria to maintain
GSIS in islet b cells.
We and others previously provided evidence that PPARa
mediates the desnutrin effect in various tissues, such as adipose
tissue and cardiac muscle (Ahmadian et al., 2011; Haemmerle
et al., 2011). We showed that desnutrin promotes a brown adi-
pose phenotype by providing a ligand(s) for PPARa, which in
turn promotes transcription of oxidative genes. Similar findings
were shown in cardiac muscle in which desnutrin/ATGL-KO
mice had lower mitochondrial oxidation with lower PPARa
expression (Hoy et al., 2011) and PPARa ligand could rescue
the mitochondrial function. Here, we propose that the role of
desnutrin in activation of PPAR family members may be tissue
specific. PPARd is more highly expressed in b cells than PPARa
and PPARg. PPARd has been shown to improve glucose respon-
siveness and insulin secretion in db/db mice (Ravnskjaer et al.,
2010; Winzell et al., 2010). It has also been reported that PPARd
serves as a FA sensor in b cells and protects against FA-induced
b cell dysfunction (Ravnskjaer et al., 2010). More importantly, we
were able to restore GSIS in desnutrin bKO mice with a PPARd
agonist, but not with a PPARa agonist, and to induce PPARd
target genes that are involved in mitochondrial oxidation.
Although desnutrin effects on mitochondrial oxidative genes
were reported to be through PPARa, PPARd was shown to be
required for a high-level expression of mitochondrial genes and
energy production in skeletal muscle and heart (Cheng et al.,
2004; Narkar et al., 2008; Wang et al., 2004). Overall, our present
studies clearly demonstrate that desnutrin-catalyzed lipolysis in
islet b cells targets PPARd, rather than PPARa, for the mainte-
nance of mitochondrial function required for GSIS. However,
the exact metabolite(s) that is generated by desnutrin-catalyzed
lipolysis to activate PPARd in islet b cells is not known. In this
regard, oxidized lipid products, such as 4-hydroxy-2E-nonenal,
that could increase insulin secretory capacity of b cells have
been proposed to be an endogenous PPARd ligand. Our desnu-
trin bKO mice may aid in the searching for specific endogenous
ligands for PPARd in promoting GSIS.
In conclusion, we show that desnutrin-catalyzed lipolysis is
required for GSIS. Specifically, we show that desnutrin activity
is necessary to promotemitochondrial function of b cells through
activation of PPARd. Targeting pathways that promote desnutrin
activity in b cells may provide strategies to help treat and/or pre-
vent dysregulation of insulin secretion.
EXPERIMENTAL PROCEDURES
Generation and Maintenance of b Cell-Specific Desnutrin Knockout
Mice
All experiments were performed on male mice at 8 weeks of age on a HFD at
weaning, except those indicated as standard chow diet. All experimental pro-
tocols used were approved by the Animal Care and Use Committee of the Uni-Cell Mversity of California, Berkeley. Mice were maintained on a HFD (45% fat, 35%
carbohydrate, and 20% protein; Research Diets) or standard chow diet ad
libitum at weaning. At 6 weeks of age, RIP-CreER mice were injected intraper-
itoneally 1 mg/day tamoxifen (Sigma) dissolved in ethanol and then in corn oil
for 5 consecutive days. Eight-week-old male mice on HFD were used for
experiments, except when indicated as fed chow diet. Generation and main-
tenance of various mouse strains are described in the Supplemental Experi-
mental Procedures.
Islet Isolation, Dispersion, and Culture of INS 832/13 Cells
Islets were isolated by collagenase (Roche) perfusion through the common bile
duct into the pancreas, and islets were dispersed by incubation with 1 mg/ml
trypsin and 30 mg/ml DNase. Islet b cells were roughly separated from a cells
by centrifugation at 800 3 g. INS 832/13 cells were provided by Dr. Chris
Newgard (Duke University).
Adenoviral Overexpression and shRNA Knockdown of Desnutrin
Adenoviral overexpression or shRNA knockdown of desnutrin in isolated
islets, dispersed islet cells, and INS 832/13 cells was performed as described
previously (Ahmadian et al., 2011). Experiments were performed 72 hr
postinfection.
Glucose and Insulin Tolerance Tests
GTT and ITT performed upon intraperitoneal injection of 2 mg/g BW of
D-glucose or 0.75 mU/g BW of insulin, respectively, as previously described
(Ahmadian et al., 2011). Tail vein bloods were collected for measurements.
Measurements for TAG Content and FA Uptake and Oxidation
Total neutral lipids were extracted from the whole pancreas, isolated islets,
and INS 832/13 cells according to Folch method. Thin-layer chromatography
was performed to separate lipids following lipid extraction. TAG levels were
measured with lipids solubilized in 1% Triton X-100 Infinity reagents (Thermo).
FA oxidation was determined upon incubation with 14C-palmitic acid
(20 mCi/ml) for 2 hr by gentle shaking. The buffer was acidified with perchloric
acid, and the 14CO2 was trapped on Whatman paper with ethanolamine
before quantification of radioactivity via scintillation counting. FA uptake was
measured by using BODIPY-labeled FA (Invitrogen) and fluorescence-
activated cell sorting (BD FACSCalibur).
H&E Staining, Immunostaining, and Nile Red Staining
For immunostaining, islets were handpicked under a stereomicroscope and
fixed in a 10% formaldehyde solution. Islets were stained with primary anti-
bodies against insulin (Cell Signaling) followed by Alexa Fluor 488 secondary
antibody staining or glucagon (Abcam) followed by Alexa Fluor 495 secondary
antibody and DAPI was used to visualize nuclei. Sections or islets were visual-
izedwith an AxioImager. Nile redwas used to stain isolated islets or INS 832/13
cells grown on coverslips and fixed in 10% formaldehyde.
RT-qPCR and Immunoblotting
RT-qPCR was performed using primers indicated in Table S1, and various
antibodies used in immunoblotting and immunoprecipitation are described
in Supplemental Experimental Procedures.
Insulin Secretion and Insulin, Glycerol, and FFA Levels
Islets or dispersed islet cells were incubated in secretagogue buffer (0.2%
BSA, 20 mM HEPES [pH 7.2], 114 mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4,
1.16 mM MgSO4, 2.5 mM CaCl2, and 3 mM glucose) for 2 hr. The buffer
was replaced with that containing varying concentrations of glucose, in the
presence or absence of 0.4 mM oleate, 30 mM KCl, and/or 250 mM diazoxide.
Insulin release wasmeasured in the SAB using ELISA (Alpco). For time-depen-
dent GSIS, media was aliquoted at various time points and centrifuged for
5 min at 4C to remove any cell debris before insulin measurement.
For insulin content, insulin was extracted from whole pancreas or isolated
islets by acid/ethanol extraction and was normalized to protein content deter-
mined by Bradford method (Bio-Rad). Measurements of glycerol and intracel-
lular free FA concentrations in isolated islets or INS 832/13 cells are described
in the Supplemental Experimental Procedures.etabolism 18, 883–895, December 3, 2013 ª2013 Elsevier Inc. 893
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Isolated islets fixed in 2% glutaraldehyde were postfixed 1% OsO4 and
embedded in an Epon-Araldite. Sections of 0.2 mm were mounted on 150-
mesh copper grids for transmission electron microscopy.
ATP/ADP Ratio and CS Activity
For determination of ATP/ADP ratio, ATP and ADP contents were measured
by fluorometric assay kit after deproteinization (BioVision). CS activity was
measured using citrate synthase assay kit (Sigma).
Measurement of OCR and MitoTracker Red/Green Staining
OCR of the isolated islets was measured in XF24 respirometer platform
(Seahorse Bioscience XF24 Extracellular Flux Analyzer). Eighty to one hundred
islets per well were preincubated for 2 hr at 37Cwithout CO2 inmedia contain-
ing 3 mM glucose, 0.8 mM Mg2+, 1.8 mM Ca2+, 143 mM NaCl, 5.4 mM KCl,
0.91 mM NaH2PO4, phenol red 15 mg/ml, and 1% fetal bovine serum. To opti-
mize the islet respiration condition, 10 mM pyruvate and 2 mM glutamine were
added into the assaymedia. Glucose at 20mMwas added to stimulate cellular
oxygen consumption. Oligomycin (5 mM), FCCP (1 mM), or Rotenone (5 mM)
were added at indicated time points.
Mitochondrial membrane potential in dispersed islet cells and in INS 832/13
cells was measured using MitoTracker red/green. Total and mtDNA from
isolated islets were extracted using phenol-chloroform method and used for
qPCR with primers indicated in Table S1.
PPAR Binding
PPARd and PPARa binding activities weremeasured by PPARa, d, gComplete
Transcription Factor Assay Kit (Cayman) using nuclear extracts from isolated
islets.
Statistical Analysis
The results are expressed as means ± SEM. An ANOVA was used for
comparisons among multiple groups with a Tukey-Kramer post hoc test and
a Student’s t test for comparisons between two groups. All significance levels
were set at p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at http://dx.
doi.org/10.1016/j.cmet.2013.10.012.
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